skip to content

Emmaus Life Sciences Wins Sweeping Summary Judgment Victory In Suit Against AFH Holding & Advisory and Amir Heshmatpour

May 16, 2013

TORRANCE, Calif., May 16, 2013 – Emmaus Life Sciences, Inc., a company dedicated to the discovery, development and commercialization of innovative and cost effective treatments and therapies for rare diseases, today announced that the Superior Court of Delaware granted in full its motion for summary judgment in the company’s lawsuit against AFH Holding & Advisory, LLC (“AFH”) and Amir Heshmatpour.